Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 1996

View Archived Issues

Bronchoselective beta-adrenergic agonists reported by Almirall

New azole antifungal agents described by Zambon

McNeil describes new antipsychotic compounds

New 5-HT1D antagonists from SmithKline Beecham

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

EGFR tyrosine kinase inhibitors from Ciba-Geigy for hyperproliferative conditions

New endothelin receptor modulators reported by Texas Biotechnology

JT discloses new compounds for Alzheimer's disease and other CNS disorders

New bisphosphonic acid derivatives from Nippon Chemiphar

Schering-Plough continues research into FPTase inhibitors

Eight presentations at the RSNA on EchoGen

Eastern European approval for Zila's oral cancer diagnostic

Beacon Diagnostics launches first product

Zeneca and Rutgers collaborate on apoptosis research

Oral influenza vaccine from Cortecs enters clinic

BMS-Aurora research agreement on screening technology

Promising clinical results reported for C. parvum therapeutic

Shionogi product pipeline in review

Calydon's lead cancer therapeutic progresses toward clinical trials

Vascular Therapeutics licenses Recordati compound

Chugai starts phase I clinical trials with phosphate binder

Alteon amends ACTION II trial

Cholesterol-lowering activity reported for Yamanouchi LTD4 antagonist

Synsorb Pk licensed to major Japanese pharmaceutical company

FDA requests additional data on H. pylori diagnostic

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Forbes Medi-Tech awarded research grant

New therapeutic approach to neurogenerative disorders

Another Barr generic drug cleared by the FDA

NIH offers licenses for invention related to fusin

NIH offers invention for treating and diagnosing HIV infection for licensing

Method of imaging nicotinic acetylcholine receptors offered for licensing

Techniclone explores MAb-based drug delivery technologies

Assay for diagnosing and monitoring kidney disease available for licensing

New nonoxynol-9 formulations tested at University of Kentucky

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...